Sign in
4

Changes in Ownership

AbCellera Biologics Inc. Filed Acc 0001834411-26-000013

Chief Financial Officer acquired 50,000 shares (option exercise)

  • Chief Financial Officer gave 50,000 shares (gift)

From the SEC's structured data for this filing

Trades in this filing

Booth Andrew · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-13 Exercise or conversion : show line 1 in the form +50,000 $0.32 $16,080 541,400 D
2026-11-13 Gift : show line 2 in the form −50,000 491,400 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-11-13 Exercise or conversion : show line 3 in the form Share option (right to buy) −50,000 8,451,849 D
Loading xslF345X06/wk-form4_1794845662.xml…